Ignite Creation Date:
2024-05-05 @ 10:41 PM
Last Modification Date:
2024-10-26 @ 10:23 AM
Study NCT ID:
NCT01169311
Status:
COMPLETED
Last Update Posted:
2014-10-06
First Post:
2010-07-22
Brief Title:
Safety and Performance of the Covidien EEA Hemorrhoid and Prolapse Stapling Set in a Hemorrhoidopexy Procedure
Sponsor:
Medtronic - MITG
Organization:
Medtronic - MITG
Study Overview
Official Title:
A Prospective Multi-Center Investigation Of The Safety And Performance Of The Covidien EEA Hemorrhoid And Prolapse Stapling Set With DST Series Technology Im A Hemorrhoidopexy Procedure
Status:
COMPLETED
Status Verified Date:
2014-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Trial Objectives
The primary objectives of this clinical trial are to estimate the Covidien EEA Hemorrhoid and Prolapse Stapling Set
overall performance defined by the successful creation of a normal staple line safety as measured by the 30 day incidence of adverse events
The primary objectives of this clinical trial are to estimate the Covidien EEA Hemorrhoid and Prolapse Stapling Set
overall performance defined by the successful creation of a normal staple line safety as measured by the 30 day incidence of adverse events
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None